Spruce Biosciences, Inc. (SPRB) vs Tenaya Therapeutics, Inc. (TNYA)

Spruce Biosciences, Inc. and Tenaya Therapeutics, Inc. are both Biotechnology companies. Spruce Biosciences, Inc. and Tenaya Therapeutics, Inc. are of similar size ($140.9M and $139.0M). Across the 10 metrics below, Spruce Biosciences, Inc. leads on 7 and Tenaya Therapeutics, Inc. on 3.

Valuation

Metric SPRB TNYA Biotechnology median
P/E n/m n/m 7.88
P/S 24.12 n/m 11.47
P/B 1.41 1.91 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 5.95 n/m 10.73
Earnings yield (81.65%) (86.89%) (28.84%)
Free cash flow yield (36.12%) (39.62%) (23.03%)

Profitability

Metric SPRB TNYA Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (105.98%) (121.86%) (57.72%)
Return on assets (82.38%) (95.61%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric SPRB TNYA Biotechnology median
Revenue growth (TTM) (51.32%) — 5.64%
EPS growth (last fiscal year) 47.59% 54.96% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SPRB TNYA Biotechnology median
Debt to equity 0.08 0.00 0.00
Current ratio 9.23 4.52 4.73
Net debt to EBITDA 1.34 1.19 0.96

Dividend

Metric SPRB TNYA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric SPRB TNYA Biotechnology median
Market cap 140.88m 139.02m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack